NCT04105959View on ClinicalTrials.gov

A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 25, 2019

Primary Completion Date

November 19, 2019

Study Completion Date

December 9, 2019

Conditions
Inflammatory Response
Interventions
DRUG

RIST4721

RIST4721 oral solution

DRUG

Placebo

Placebo oral solution

Trial Locations (1)

M13 9NQ

MAC Clinical Research, Manchester

Sponsors
All Listed Sponsors
lead

Aristea Therapeutics, Inc.

INDUSTRY

NCT04105959 - A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model | Biotech Hunter | Biotech Hunter